ALNY
ALNY
US02043Q1076
Alnylam Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
31.13B EUR
40.26B EUR
44.15B EUR
52.64B EUR
Enterprise Value
29.72B EUR
39.82B EUR
43.71B EUR
52.26B EUR
Valuation Multiples
Trailing P/E
39.24x
49.82x
77.29x
144.11x
Forward P/E
18.73x
--
--
--
Price to Sales
6.48x
8.38x
10.3x
16.87x
Price to Book
22.98x
29.73x
41.06x
66.7x
EV/Revenue
6.19x
8.29x
10.2x
16.75x
EV/EBITDA
28.19x
34.69x
48.14x
86.59x
Price to FCF (P/FCF)
114.66x
49.1x
68.63x
88.52x
EV/FCF
109.46x
48.57x
67.95x
87.88x
FCF Yield
0.87%
2.04%
1.46%
1.13%
ende